Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2025-12-26 @ 7:42 PM
Study NCT ID:
NCT00423566
Status:
COMPLETED
Last Update Posted:
2007-01-18
First Post:
2007-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.
Sponsor:
University of Oxford
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-09
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2003-07
Completion Date Type:
None
First Submit Date:
2007-01-17
First Submit QC Date:
None
Study First Post Date:
2007-01-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-01-17
Last Update Post Date:
2007-01-18
Last Update Post Date Type:
ESTIMATED